Literature DB >> 1178811

Membranous nephropathy. Long-term follow-up and association with neoplasia.

P G Row, J S Cameron, D R Turner, D J Evans, R H White, C S Ogg, C Chantler, C B Brown.   

Abstract

Sixty-six patients of all ages whose renal biopsy appearances satisfied strict criteria for the histopathological diagnosis of membranous nephropathy were studied and followed for a mean of 5-4 years (range 1 to 20 years). From initial investigation seven patients were found to have associated neoplasia, and in two patients the condition followed treatment with a mercurial diuretic and gold. One patient was Australia antigen positive. Two patients developed renal vein thrombosis, but in both this appeared to follow not precede their nephrotic syndrome. In the remaining 56 patients there was no associated factor. During the follow-up period, approximately one-quarter of the patients (15) died, nine from renal failure; one-quarter (10) had a persistent nephrotic syndrome, another one-quarter (15) proteinuria of lesser degree. The final one-quarter (16) are now in complete remission. The prognosis of the 54 patients with an initial nephrotic syndrome was poorer than the 12 with lesser proteinuria and no oedema at onset; five of 11 children were in complete remission when last seen. All but one of the nine patients who developed terminal chronic renal failure 4 to 18 years from onset had an unremitting nephrotic syndrome, eight of the 10 currently alive with a persistent nephrotic syndrome have reduced renal function. Renal functional deterioration did not occur in the absence of proteinuria. There was only slight correspondence between the stage of biopsy appearance, glomerular filtration rate at time of biopsy, time of the biopsy from apparent onset, or status at last follow-up. Staging is therefore of limited prognostic value. Twenty-two patients were treated with corticosteroids for 2 to 36 months; we detected no short or long-term benefit when compared to patients not so treated.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1178811

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  28 in total

1.  Membranous glomerulonephritis, dermatomyositis, and bronchial carcinoma.

Authors:  J D Rose
Journal:  Br Med J       Date:  1979-09-15

2.  Two children with kidney disease. Demonstrated at the Royal College of Physicians of London.

Authors: 
Journal:  Br Med J       Date:  1978-09-23

3.  Chemotherapy influencing the course of nephrotic syndrome in colonic carcinoma.

Authors:  D Goldstein; R Kelly; M Ralston; R Penny; J Hayes
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

4.  Long-term effects of steroid and cytostatic treatment on the clinical course of idiopathic membranous glomerulonephritis (retrospective study).

Authors:  G Mohácsi; A Magori; S Sonkodi
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

5.  Relapse of Henoch-Schönlein disease associated with lung carcinoma.

Authors:  D M Mitchell; B I Hoffbrand
Journal:  J R Soc Med       Date:  1979-08       Impact factor: 5.344

Review 6.  Therapy of idiopathic membranous nephropathy.

Authors:  C Ponticelli; P Zucchelli; P Passerini
Journal:  Springer Semin Immunopathol       Date:  1987

7.  Membranous nephropathy: high-dose alternate-day therapy with prednisone.

Authors:  J Hopper; C G Biava; W H Tu
Journal:  West J Med       Date:  1981-07

Review 8.  Membranous nephropathy associated with ovarian tumour in a young girl: recovery after removal.

Authors:  P Beauvais; G Vaudour; L Boccon Gibod; M Levy
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

Review 9.  The association of non-Hodgkin's lymphoma with glomerulonephritis.

Authors:  J A Girón González; M Yebra Bango; F Merino Morales; J L Menéndez Caro; F J Diego Marín; A Durántez Martínez
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

10.  Nature of the glomerular capillary injury in human membranous glomerulopathy.

Authors:  O Shemesh; J C Ross; W M Deen; G W Grant; B D Myers
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.